Omalizumab is an effective add-on therapy in moderate-to-severe allergic asthma

Author: Adis International Limited  

Publisher: Adis International

ISSN: 1172-0360

Source: Drugs & Therapy Perspectives, Vol.21, Iss.7, 2005-07, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract